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ABSTRACT
Although Sgf73p, a yeast homologue of human
Sca7p, has recently been implicated as a new com-
ponent of Spt-Ada-Gcn5-acetyltransferase (SAGA),
its association with SAGA and functional role in
regulation of transcription remain unknown in vivo.
Here, using a chromatin immunoprecipitation (ChIP)
assay, we show in vivo that, like SAGA, Sgf73p is
recruited to the upstream activating sequence (UAS)
of a SAGA-dependent gene, GAL1, in an activator-
dependent manner. Further, Sgf73p is required for
recruitment of SAGA to the GAL1 UAS, and facili-
tates formation of the preinitiation complex (PIC)
assembly at the GAL1 promoter. When PIC is not
formed in Dsgf73, histone H3 is not evicted from the
GAL1 promoter. Interestingly, PIC formation at
GAL1 is not regulated by histone H3 acetylation or
histone acetyltransferase (HAT) activity of SAGA.
Similarly, Sgf73p facilitates PIC formation at another
SAGA-dependent gene, ADH1, independent of his-
tone H3 acetylation or HAT. In contrast, Sgf73p
stimulates PIC formation at PHO84 (a SAGA-
dependent gene), in a HAT-dependent-manner.
Collectively, our data reveal that Sgf73p is required
for SAGA recruitment, and stimulates PIC formation
either in a HAT-dependent or -independent manner,
providing significant information on how Sgf73p
and possibly human Sca7p function physiologically.
INTRODUCTION
Spt-Ada-Gcn5-acetyltransferase (SAGA), a large multi-
protein complex with Gcn5p-HAT (histone acetyltransferase)
activity, is required for the normal transcription of  10%
of yeast genes (1). The role of SAGA in transcriptional
activation has been studied extensively at GAL1 (2–8). At
the GAL1 promoter, the activator Gal4p ﬁrst recruits SAGA
to the upstream activating sequence (UAS), and then the
UAS-bound SAGA facilitates recruitment of TATA-box
binding protein (TBP) to the core promoter, thereby stimulat-
ing formation of preinitiation complex (PIC) and hence
transcription (5,7,8).
Recently, Sgf73p has been biochemically identiﬁed as a
new component of SAGA (9,10). Sgf73p is a yeast homolo-
gue of the human Spinocerebellar ataxia type 7 (SCA7) gene
product, ataxin-7 or Sca7p. It is one of the eight known
autosomal dominant neurodegenerative disorders which are
caused by CAG (that encodes glutamine, Q) nucleotide repeat
expansions from <35 (non-pathogenic) to an extreme of 300
(pathogenic) copies (11–15). However, it is not known how
CAG nucleotide repeat expansion within ataxin-7 causes
neurodegenerative diseases. Recent biochemical studies
(16,17) have demonstrated that, like Sgf73p, wild-type
ataxin-7 is a component of mammalian SPT3-TAFII31-
GCN5L acetylase (STAGA) transcription coactivator com-
plex (18,19), a human homologue of yeast SAGA complex,
and it regulates HAT activity of STAGA and its interaction
with activators. The poly(Q)-expanded ataxin-7 gets incorpo-
rated into STAGA as well as SAGA (10,16), but inhibits
Gcn5p-HAT activities of both STAGA and SAGA (10,16),
and thus alters gene expression, providing signiﬁcant
information on the molecular basis of poly(Q) disorders.
Although previous biochemical studies (10,16,17) have
deﬁned the functional roles of Sgf73p and ataxin-7 in main-
taining the overall structural integrities of SAGA and
STAGA, respectively, and their HAT activities, the molecular
role of Sgf73p or ataxin-7 in transcriptional regulation
remains mostly unknown in vivo. Here, using a formal-
dehyde-based in vivo crosslinking and chromatin immunopre-
cipitation (ChIP) assay, we have analyzed the role of Sgf73p
in recruitment of SAGA and formation of the PIC assembly
(and hence transcription) at the SAGA-dependent promoter
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the role of histone H3 acetylation or the HAT activity of
SAGA in regulation of the PIC formation at the SAGA-
dependent promoters in vivo. Our results reveal that Sgf73p
is required for SAGA recruitment and stimulates formation
of the PIC assembly at the SAGA-dependent promoters.
Consistently, transcription of the SAGA-regulated genes is
signiﬁcantly impaired in Dsgf73. Interestingly, PIC formation
at the SAGA-regulated genes is differentially regulated
by histone H3 acetylation or the HAT activity of SAGA
in vivo.
MATERIALS AND METHODS
Plasmids
Plasmid SGP4 was generated by cloning a DNA fragment
containing three Gal4p-binding sites into the low copy
number plasmid pRS416 (5). The plasmid pFA6a-13Myc-
KanMX6 (20) was used for genomic myc epitope-tagging
of the proteins of interest. The Plasmid pRS416 (21) was
used in the PCR-based gene disruption.
Yeast strains and media
Yeast strain harboring null mutation in GCN5 (FY1370), and
its isogenic wild-type equivalent FY1369 were obtained from
Fred Winston (Harvard Medical School, Boston, MA) (2).
Multiple myc-epitope tags were added at the original chromo-
somal locus of SGF73 in W303a to generate ASY3 (Sgf73p-
myc, Kan). The plasmid SGP4, carrying three Gal4p-binding
sites, was transformed into ASY3 to generate ASY6. The
endogenous SGF73 gene of W303a was disrupted using the
PCR-based gene knock-out method (22) to generate ASY9
(Dsgf73::URA3). Multiple myc-epitope tags were added at
the original chromosomal locus of SPT20 in W303a and
ASY9 to generate ASY10 (Spt20p-myc, Kan) and ASY13
(Spt20p-myc, Kan; Dsgf73), respectively.
For the studies at the GAL1 promoter in Dsgf73 and Dgcn5
mutant strains, and their isogenic wild-type equivalents, cells
were ﬁrst grown in YPR (yeast extract containing peptone
plus 2% rafﬁnose) to an optical density at 600 nm (OD600)
of 0.9 and then transferred to YPG (yeast extract–peptone
plus 2% galactose) for 90 min at 30 C prior to formaldehyde
crosslinking. Minimal media containing either 2% galactose
or rafﬁnose were used for the strain (ASY6) with reporter
plasmid, SGP4. The yeast strains were grown in YPD
(yeast extract containing peptone plus 2% dextrose) to an
OD600 of 1.0 at 30 C for the studies at the ADH1, PHO84
and RPS5 promoters.
ChIP assay
The ChIP assay was performed as described previously
(23,24). Brieﬂy, yeast cells were treated with 1% formalde-
hyde, collected and resuspended in lysis buffer. Following
sonication (that generates the average size of  400 bp of
sheared DNA), cell lysates (400 ml lysate from 50 ml of
yeast culture) were precleared by centrifugation, and then
100 ml lysate was used for each immunoprecipitation (IP).
Immunoprecipitated (IP) protein–DNA complexes were
treated with proteinase K, the crosslinks were reversed, and
the DNA was puriﬁed. IP DNA was dissolved in 20 mlT E
8.0 [10 mM Tris–HCl (pH 8.0) and 1 mM EDTA], and
1 ml of IP DNA was analyzed by PCR. The PCR (a total of
23 cycles) contained [a-32P]dATP (2.5 mCi for each 25 ml
reaction) and the PCR products were detected by autoradio-
graphy after separation on a 6% polyacrylamide gel. As a
control, ‘input’ DNA was isolated from 5 ml lysate without
going through the IP step and suspended in 100 ml TE 8.0.
To compare the PCR signal arising from the IP DNA with
the input DNA, 1 ml of input DNA was used in PCR analysis.
For analysis of histone H3 levels at the promoters, we
modiﬁed the above ChIP protocol as follows. Eight hundred
microlitre lysate was prepared from 100 ml of yeast culture.
Four hundred microlitre lysate was used for each IP (using
5 ml of anti-histone H3 antibody from Abcam and 100 ml
of protein A/G plus agarose beads from Santa Cruz Biotech-
nology, Inc.), and IP DNA sample was dissolved in 10 mlT E
8.0 of which 1 ml was used in PCR analysis. In parallel, the
PCR for ‘input’ DNA was performed using 1 ml DNA that
was prepared by dissolving puriﬁed DNA from 5 ml lysate
in 1000 ml TE 8.0.
Serial dilutions of the input and IP DNAs were used to
asess the linear range of PCR ampliﬁcation as described pre-
viously (6). The PCR data presented in this paper are within
the linear range of PCR analysis. All the ChIP experiments
were repeated at least three times and consistent results were
obtained. Primer-pairs used for PCR analysis were as follows:
GAL1(UAS): 50-CGCTTAACTGCTCATTGCTATATTG-30,
50-TTGTTCGGAGCAGTGCGGCGC-30; GAL1(Core):
50-ATAGGATGATAATGCGATTAGTTTTTTAGCCTT-30,
50-GAAAATGTTGAAAGTATTAGTTAAAGTGGTTATGCA-
30; ADH1(Core): 50-GGTATACGGCCTTCCTTCCAGT-
TAC-30,5 0-GAACGAGAACAATGACGAGGAAACAA-
AAG-30; PHO84(Core): 50-GATCCACTTACTATTGTG-
GCTCGT-30,5 0-GTTTGTTGTGTGCCCTGGTGATCT-30;
RPS5(Core): 50-GGCCAACTTCTACGCTCACGTTAG-30,
50-CGGTGTCAGACATCTTTGGAATGGTC-30; GAL4
[open reading frame (ORF)]: 50-CTTGTTCAATGCAGTC-
CTAGTACCC-30,5 0-CACAAGTCTGGATTTTAAAAGT-
GGCC-30.
Primers ﬂanking Gal4p-binding sites in the plasmid
SGP4 are 50-GGTGGCGGCCGCTCTAGAACTAGT-30 and
50-TTGACCGTAATGGGATAGGTCACG-30.
Autoradiograms were scanned and quantitated by the
National Institutes of Health image 1.62 program. The ratio
of IP DNA over the input was presented as %IP. For mutant
strains, DNA IP relative to wild-type (WT) was presented as
%WT.
Primer extension analysis
Primer extension analysis was performed as described
previously (5–7,23,25,26). Brieﬂy, total RNA was prepared
from 10 ml of yeast culture. Fifteen micrograms of total RNA
was used in the primer extension analysis using
32P-labeled
primer and AMV reverse transcriptase (Promega). The
primers used for analysis of GAL1, ADH1, PHO84 and RPS5
mRNAs were as follows: GAL1: 50-CCTTGACGTTACC-
TTGACGTTAAAGTATAGAGG-30; ADH1:5 0-TATCCTT-
GTGTTCCAATTTACCGTGG-30; PHO84:5 0-GAAGACT-
TCTTTCAGCAACATG-30; RPS5:5 0-GACTGGGGTGAAT-
TCTTCAACAACTTC-30.
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Sgf73p is an integral component of SAGA in vivo
Yeast SAGA is a large multi-protein complex that contains
Ada1p, Ada2p, Ada3p, Ada5p/Spt20p, Spt3p, Spt7p, Spt8p,
Gcn5p, Tra1p, TAF5p, TAF6p, TAF9p, TAF10p, TAF12p,
Ubp8p, Chd1 and Sgf11 (9,27–35). Recently, Sgf73p has
been biochemically implicated as a new component of SAGA
(10). To conﬁrm whether Sgf73p is a new component of
SAGA in vivo, we analyzed recruitment of Sgf73p to the
UAS of a well-characterized SAGA-dependent gene, GAL1,
using a ChIP assay. We used either a c-myc mouse monoclo-
nal antibody and yeast strains expressing a C-terminal
myc epitope-tagged Sgf73p or polyclonal antibody to
SAGA TAF (e.g. TAF12p). Two sets of promoter-speciﬁc
primer-pairs were used that, as shown below in Figure 1A,
could distinguish binding to the GAL1 UAS or core promoter.
If Sgf73p is an integral component of the SAGA complex,
it would be recruited to the GAL1 UAS, but not core promo-
ter, since previous ChIP studies (5) have demonstrated
recruitment of SAGA to the GAL1 UAS.
Figure 1A shows that under condition in which Gal4p
activation domain was active (galactose-containing growth
medium), the TAF12p subunit of SAGA as well as Sgf73p
were present at the GAL1 UAS. Similarly, Gal4p was
recruited to the GAL1 UAS (Figure 1A). Signiﬁcantly,
these same proteins were not associated with the GAL1
core promoter as well as an irrelevant DNA sequence
(GAL4 ORF) (Figure 1A). These observations supported the
possibility that Sgf73p is a component of SAGA in vivo.
However, because these experiments were performed with
the intact GAL1 promoter, it remained possible that other
transcription components, such as general transcription
factors (GTFs) played a role in recruitment of Sgf73p to
the UAS. To address this issue, we asked whether Sgf73p
could be recruited by Gal4p to a plasmid bearing only
Gal4p-binding sites, but not other promoter elements.
Figure 1B shows that Sgf73p was recruited to a plasmid
bearing Gal4p-binding sites in galactose-containing growth
medium in which Gal4p activation domain was active.
Signiﬁcantly, Sgf73p was not associated with the Gal4p-
binding sites when Gal4p activation domain was inactive
(rafﬁnose-containing growth medium) even though the level
of Gal4p recruitment was almost equal to that in galactose-
containing growth medium (Figure 1B). Further, our previous
studies (5) have demonstrated that, like Sgf73p, other SAGA
components, such as Spt3p and Spt20p, were also recruited to
the minimal Gal4p-binding sites in the plasmid in galactose-
containing growth medium. Signiﬁcantly, the GTFs, such as
TBP, TFIIB, Mediator and RNA polymerase II, were not
recruited to the minimal Gal4p binding sites in the plasmid
(5). Taken together, our data provide evidence that Sgf73p
is a new component of the SAGA complex in vivo, consistent
with previous biochemical data (9,10).
Sgf73p regulates the integrity of SAGA in vivo
To understand the role of the newly identiﬁed Sgf73p
component of SAGA in transcriptional activation in greater
detail, it is necessary to determine its contribution in
maintaining the integrity of SAGA. Recently, McMahon
et al. (10) have demonstrated biochemically that Sgf73p is
required to maintain SAGA integrity. Similarly, if Sgf73p
maintains SAGA integrity in vivo, Spt20p and other SAGA
components will not be recruited to the GAL1 UAS in the
Dsgf73 strain. To test this idea, we analyzed recruitment of
SAGA to the GAL1 UAS in the SGF73 deletion mutant.
Figure 2A shows that the deletion of SGF73 signiﬁcantly
lowered recruitment of the Spt20p and TAF10p components
of SAGA to the GAL1 UAS. Similarly, our previous studies
(5,6) have also demonstrated that recruitment of SAGA was
lost in the SPT20 [that integrates SAGA (3)] deletion mutant
strain. On the other hand, recruitment of the SAGA compo-
nents such as TAF10p, TAF12p and Spt3p was not altered
Figure 1. Recruitment of Sgf73p to the GAL1 UAS or minimal Gal4p binding
site. (A) Recruitment of Sgf73p to the UAS, but not core promoter, of the
GAL1 gene. Yeast strain expressing myc-epitope tagged Sgf73p was grown at
30 C in 1% yeast extract containing 2% peptone plus 2% galactose (YPG) up
to an OD600 of 1.0 prior to formaldehyde-based in vivo crosslinking. The
chromatin (IP) was performed as previously described (23,24). Primer-pair
located at the UAS or core promoter of the GAL1 gene (see Materials and
Methods section) was used for PCR analysis of the (IP) DNA samples. A PCR
fragment corresponding to the GAL4 ORF was used as a control for
background binding. (IP) was performed using a mouse monoclonal antibody
against the c-myc epitope-tag (9E10; Santa Cruz Biotechnology, Inc.) or a
polyclonal antibody against TAF12p (from Michael R. Green, University of
Massachusetts Medical School). A mouse monoclonal antibody against the
DNA binding domain of Gal4p (RK5C1; Santa Cruz Biotechnology, Inc.)
was used. The primer-pairs are indicated on the left. The ratio of
immunoprecipitate over the input is indicated below each band as %IP.
(B) Recruitment of Sgf73p to the minimal Gal4p-binding sites. The plasmid
containing minimal Gal4p-binding sites was transformed into the yeast strain
expressing myc-epitope tagged Sgf73p. Yeast strain thus generated, was
grown at 30 C in 1% yeast extract containing 2% peptone plus 2% galactose
or raffinose. The ChIP analysis was performed as described in (A). The
primers used for the PCR analysis are adjacent to the Gal4p-binding sites in
the plasmid (see Materials and Methods section). The growth media are
indicated on the left.
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integrity of SAGA (3). Since Spt20p maintains the integrity
of SAGA (3,5) and its recruitment was signiﬁcantly reduced
in the absence of Sgf73p (Figure 2A), thus Sgf73p, like
Spt20p, seems to regulate the structural integrity of the
SAGA complex in vivo, consistent with previous biochemical
data (10). However, our ChIP data also raised the possibility
that Sgf73p might be required for recruitment of Spt20p
(and hence SAGA) to the GAL1 UAS by its interaction
with the activator, Gal4p. In fact, our previous studies (7)
have demonstrated that SAGA is recruited to the GAL1
UAS by interaction of its Tra1 subunit with Gal4p in vivo.
Thus, it is more likely that Sgf73p is required to maintain
the integrity of SAGA in vivo, consistent with previous
biochemical studies (10).
Sgf73p facilitates formation of the PIC assembly at the
core promoters of the SAGA-dependent genes in vivo
To better understand the role of Sgf73p in formation of the
PIC assembly and hence transcriptional activation, we
analyzed its contribution in recruitment of TBP and RNA
polymerase II (two important components of the PIC assem-
bly) to the GAL core promoter. Figure 2B shows that recruit-
ment of TBP and the largest subunit (Rpb1p) of RNA
polymerase II to the GAL1 core promoter was dramatically
reduced in the SGF73 deletion mutant strain. Consistently,
transcription of GAL1 was signiﬁcantly impaired in Dsgf73
(Figure 2C). Thus, the Sgf73p component of SAGA regulates
GAL1 transcription by facilitating formation of PIC at the
core promoter. However, formation of the PIC assembly at
the GAL1 core promoter was not completely impaired in
Dsgf73. On the other hand, our previous studies (5,6) have
demonstrated that PIC formation at the GAL1 core promoter
was completely impaired in the absence of Spt20p which
maintains SAGA integrity. Such a discrepancy in PIC forma-
tion in the absence of Sgf73p or Spt20p is due to the fact that
the loss of Spt20p leads to complete impairment of SAGA
recruitment to the GAL1 UAS (5,6) while SAGA recruitment
was not completely lost in Dsgf73 (Figure 2A). Consistently,
SAGA has been shown biochemically to be completely disin-
tegrated in the absence of Spt20p but not Sgf73p (3,10).
Since Sgf73p regulates recruitment of SAGA, the forma-
tion of the PIC assembly at the SAGA-dependent promoters
in general would be altered in Dsgf73. To test this idea, we
analyzed recruitment of TBP and RNA polymerase II to the
core promoters of two other SAGA-dependent genes, namely
ADH1 and PHO84 (6). Figure 3A shows that recruitment of
TBP and RNA polymerase II to the ADH1 and PHO84 core
promoters was signiﬁcantly reduced in Dsgf73. Consistently,
transcription of these genes was also altered in the SGF73
deletion mutant strain (Figure 3B). As a negative control,
we demonstrate that the formation of the PIC assembly
(and hence transcription) at a SAGA-independent gene,
RPS5, was not altered in Dsgf73 (Figure 3C). Thus, SAGA-
associated Sgf73p regulates gene expression by stimulating
formation of the PIC assembly in vivo. However, such a func-
tion of Sgf73p in PIC formation seems to be mediated by the
regulatory role of Sgf73p in recruitment of SAGA or its
integrity. In addition, Sgf73p may also contact with the
component(s) of the PIC assembly to promote PIC formation.
Formation of the PIC assembly is differentially
regulated by HAT or histone H3 acetylation in vivo
SAGA-associated Gcn5p acetylates primarily histone H3 at
K9 (lysine 9) and K14. Histone H3 acetylation or the HAT
activity of SAGA has been previously implicated in regula-
tion of transcriptional initiation (3,36–41). However, how his-
tone H3 acetylation or HAT regulates PIC formation and
hence transcriptional initiation is not clearly known in vivo.
Thus, we asked whether formation of Sgf73p-mediated PIC
assembly at the core promoters of the aforementioned
SAGA-dependent genes is dependent on histone H3 acetyla-
tion or HAT. To address this question, we analyzed recruit-
ment of TBP and RNA polymerase II to the core promoters
Figure 2. Requirement of Sgf73p for recruitment of SAGA and formation of
the PIC assembly at GAL1.( A) Sgf73p is required for recruitment of SAGA
to the GAL1 UAS. The SGF73 deletion mutant and its isogenic wild-type
equivalent were first grown in raffinose-containing (YPR) and then shifted to
galactose-containing (YPG) growth media 90 min before treatment with
formaldehyde. (IPs) were performed as described in Figure 1A. A polyclonal
antibody against the TAF10p (from Michael R. Green, University of
Massachusetts Medical School) was used. Primer-pair located at the GAL1
UAS was used for PCR analysis of the IP DNA samples. The percentage of
DNA immunoprecipitated relative to wild-type (%WT) is indicated below
each band of the mutant strains. (B) Sgf73p is required for formation of the
PIC assembly at the GAL1 core promoter. Yeast strains were grown,
crosslinked and immunoprecipitated as in panel A. Primer-pair located at the
GAL1 core promoter was used for PCR analysis of the immunoprecipitated
DNA samples. IPs were performed using polyclonal antibodies against TBP
(obtained from Michael R. Green, University of Massachusetts Medical
School) and the mouse monoclonal antibody 8WG16 (Covance) against the
carboxy terminal domain of the RNA polymerase II large subunit (Rpb1p).
(C) Transcription. Total cellular RNA was prepared from the wild-type or
Dsgf73, and mRNA level from the GAL1 gene was quantitated by primer-
extension. The percentage transcription relative to wild-type is indicated
below.
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mutant and its isogenic wild-type equivalent. Figure 4A
shows that the GAL1, PHO84 and ADH1 core promoters
were acetylated at histone H3. Histone H3 acetylation at
these core promoters were signiﬁcantly reduced in Dgcn5.
Interestingly, such a reduction in the level of histone H3 acet-
ylation did not alter recruitment of RNA polymerase II and
TBP to the GAL1 and ADH1 core promoters (Figure 4B).
Thus, at these two promoters, Sgf73p facilitates formation
of the PIC assembly in a HAT-independent-manner. In con-
trast, recruitment of RNA polymerase II and TBP to the
PHO84 core promoter was dependent on histone H3 acetyla-
tion or Gcn5p-HAT (Figure 4A and B), demonstrating the
requirement of histone H3 acetylation or HAT for formation
of the PIC assembly. Thus, our data demonstrate that histone
H3 acetylation or the HAT activity of SAGA is differentially
required for formation of the PIC assembly in vivo, revealing
a complex regulation of the PIC formation.
Role of Sgf73p in regulation of histone H3 acetylation or
histone H3 eviction at the SAGA-dependent promoters
We next asked whether Gcn5p-HAT activity of SAGA is
regulated by Sgf73p in vivo. Previous biochemical studies
(36) have demonstrated that Gcn5p-HAT activity on nucleo-
somal histone H3 is dependent on the Ada2p and Ada3p com-
ponents of SAGA. Similarly, deletion of SGF73 has been
shown to biochemically impair the HAT activity of SAGA
(10). However, it is not known whether Sgf73p regulates his-
tone H3 acetylation at the promoters of the SAGA-dependent
genes in vivo. To address this question, we analyzed the
levels of histone H3 acetylation at the GAL1 core promoter
in the SGF73 wild-type and deletion mutant strains. Since
Sgf73p is required for recruitment of Gcn5p as well as
SAGA, histone H3 acetylation at the GAL1 core promoter
is expected to be signiﬁcantly impaired in Dsgf73. Interest-
ingly, our ChIP data demonstrate the elevated level of histone
H3 acetylation at the GAL1 core promoter in Dsgf73 when
compared with wild-type equivalent (Figure 5A). Likewise,
the elevated levels of histone H3 acetylation were also
observed at the ADH1 and PHO84 core promoters in
Dsgf73 (Figure 5A). In contrast, histone H3 acetylation
level at the core promoter of a SAGA-independent RPS5
gene was not altered in the absence of Sgf73p (Figure 5A).
Since H3-K9/14 acetylation antibody also recognizes unace-
tylated histone H3 (Upstate biotechnology, Inc.; Figure 4A),
the increase in the levels of histone H3 acetylation at the core
promoters of GAL1, ADH1 and PHO84 in Dsgf73 may be
Figure 3. Sgf73p is required for PIC formation (and hence transcriptional
activation) at the ADH1 and PHO84 promoters. (A) The analysis of the PIC
assembly at the ADH1 and PHO84 core promoters in Dsgf73. The yeast
strains were grown in YPD at 30 Cu pt oa nO D 600 of 1.0 prior to
crosslinking. IPs were performed as described in Figure 2B. Primer-pairs
located at the ADH1 and PHO84 core promoters were used for PCR analysis
of the immunoprecipitated DNA samples. (B) Transcription. Total cellular
RNA was prepared from the wild-type or Dsgf73, and mRNA levels from
the ADH1 and PHO84 genes were quantitated by primer-extension. (C)
Sgf73p is not required for PIC formation (and hence transcription) at the
RPS5 promoter. Left panel: Analysis of recruitment of RNA polymerase II
at the RPS5 core promoter in the wild-type and SGF73 deletion mutant
strains. Both the wild-type and deletion mutant strains were grown,
crosslinked and immunoprecipitated as in panel A. Primer-pair located at
the RPS5 core promoter was used for PCR analysis of the IP DNA samples.
Right panel: Transcription. Total cellular RNA was prepared from the wild-
type or Dsgf73, and mRNA level from the RPS5 gene was quantitated by
primer-extension.
Figure 4. Histone H3 acetylation differentially regulates formation of the PIC
assembly at the core promoters of the SAGA-dependent genes. (A) The levels
of histone H3 acetylation at the GAL1, ADH1 and PHO84 promoters are
significantly reduced in the GCN5 deletion mutant. The wild-type and GCN5
deletion mutant strains were grown and crosslinked as described in Materials
and Methods section. IP was performed using a rabbit polyclonal antibody
against Lys-9/14 di-acetylated H3 (06–599, Upstate Biotechnology, Inc.). (B)
Gcn5p is required for formation of the PIC assembly at the PHO84 core
promoter, but not GAL1 and ADH1 core promoters. Yeast strains were grown
and crosslinked as in (A). IPs were performed as in Figure 2B.
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promoters of these genes, possibly because of reduction of
histone H3 eviction in the absence of the PIC formation or
active transcription (37). To test this possibility, we analyzed
the levels of histone H3 at the GAL1, ADH1 and PHO84 core
promoters in the SGF73 deletion mutant strain and its
isogenic wild-type equivalent. Figure 5B shows that the
levels of histone H3 at the core promoters of GAL1, ADH1
and PHO84, but not RPS5, were elevated in Dsgf73. Interest-
ingly, the increase in the level of histone H3 acetylation is
remarkably similar to that of histone H3 at each of the
SAGA-dependent promoters in Dsgf73. Thus, Sgf73p does
not seem to elevate the relative level of histone H3 acetyla-
tion or the HAT activity of Gcn5p in vivo. Nonetheless, our
data reveal that the loss of Sgf73p lowers histone H3 eviction
from the SAGA-dependent promoters in vivo.
DISCUSSION
Although Sgf73p has been shown to be a new component of
SAGA on the basis of the biochemical studies (9,10), it is not
known whether Sgf73p is a SAGA component in vivo. If so, it
would be recruited along with other SAGA components to the
GAL1 UAS but not to its core promoter, since SAGA is spe-
ciﬁcally recruited to the GAL1 UAS by the activator Gal4p
(5,7). Here, we show that, like SAGA, Sgf73p is recruited
to the GAL1 UAS, but not core promoter, or even to the
minimal Gal4p-binding sites in a plasmid, implicating
Sgf73p as a SAGA component in vivo. Furthermore, we
show that the deletion of SGF73 signiﬁcantly impairs recruit-
ment of the SAGA complex, consistent with biochemical
requirement of Sgf73p for SAGA integrity (10). Thus, our
results support the fact in vivo that Sgf73p is a SAGA
component and is required for the structural integrity of
SAGA, consistent with recent biochemical data (9,10).
Since Sgf73p is essential for recruitment of SAGA, the PIC
would thus not be formed at the SAGA-dependent promoters
in Dsgf73. Indeed, our study demonstrates that recruitment of
the PIC components such as TBP and RNA polymerase II is
signiﬁcantly impaired at the core promoters of the three
representative SAGA-dependent genes, GAL1, ADH1 and
PHO84, in the absence of Sgf73p. Consistently, transcription
of these genes is altered in Dsgf73. However, whether Sgf73p
plays a dual role in assembling PIC by interacting with
the component(s) of PIC as well as maintaining structural
integrity of SAGA to regulate gene expression remains to
be elucidated.
Previous studies (3,38–41) have demonstrated the func-
tional role of histone H3 acetylation at the promoters in reg-
ulation of transcriptional initiation. Here, we demonstrate that
all three SAGA-dependent promoters are acetylated at his-
tone H3. Acetylation of histone H3 at these promoters is sig-
niﬁcantly lost in Dgcn5. However, formation of the PIC
assembly at the GAL1 and ADH1 promoters is not altered
in Dgcn5. Thus, our study reveals that histone H3 acetylation
status does not regulate PIC formation at GAL1 and ADH1.I n
contrast, PIC formation is signiﬁcantly reduced at the PHO84
promoter in Dgcn5, demonstrating the role of histone H3
acetylation in regulation of the PIC formation, consistent
with previous studies (3,38–41). Thus, our study reveals
that histone H3 acetylation differentially regulates formation
of the PIC assembly. However, the molecular basis for such
differential roles of histone H3 acetylation in regulation of
the PIC formation remains unknown. According to the
‘histone-code’ hypothesis (42), it is likely that histone H3
Figure 5. Elevation of the levels of histone H3 as well as histone H3
acetylation at the core promoters of GAL1, ADH1 and PHO84 in Dsgf73.( A)
Analysis of the levels of histone H3 acetylation at the promoters of GAL1,
ADH1, PHO84 and RPS5 in the SGF73 deletion mutant strain. The wild-type
and SGF73 deletion mutant strains were grown, crosslinked and immuno-
precipitated as in Figure 4A. The percentages of DNA immunoprecipitated in
Dsgf73 relative to wild-type (%WT) at the core promoters of GAL1, ADH1,
PHO84 and RPS5 are plotted in the form of a histogram. (B) Analysis of the
levels of histone H3 at the promoters of GAL1, ADH1, PHO84 and RPS5 in
the SGF73 deletion mutant strain. The wild-type and SGF73 deletion mutant
strains were grown and crosslinked as in panel A. IP was performed using an
anti-histone H3 antibody (Ab1791; Abcam) and a modified ChIP protocol as
described in Materials and Methods section.
6230 Nucleic Acids Research, 2006, Vol. 34, No. 21acetylation in combination with other histone modiﬁcations at
the GAL1 and ADH1 promoters may contribute to the role of
chromatin structure in PIC formation and hence
transcriptional activation.
Histones are evicted during active transcription in vivo
(37). Since Sgf73p is required for formation of the PIC
assembly (and hence transcriptional activation), histone evic-
tion from the SAGA-dependent promoters would thus be sig-
niﬁcantly reduced in Dsgf73. Indeed, our study demonstrates
the elevated levels of histone H3 at the SAGA-dependent
promoters in the absence of Sgf73p. Thus, impairment of
PIC formation in Dsgf73 decreases histone H3 eviction and
hence alters chromatin structure at the SAGA-dependent
promoters.
In summary, we provide evidence that Sgf73 is a
component of the SAGA complex in vivo, consistent with
previous biochemical data (9,10). Sgf73p regulates SAGA
recruitment, and is required for the assembly of PIC at the
core promoters of the SAGA-dependent genes. However,
formation of the PIC assembly at the core promoters is differ-
entially regulated by histone H3 acetylation or Gcn5p-HAT
activity of SAGA. Further, impairment of PIC formation in
Dsgf73 lowers histone H3 eviction from the SAGA-dependent
promoters, and thus alters chromatin structure. These results
provide valuable information on the functional role of yeast
Sgf73p (and possibly human ataxin-7 or Sca7p) in regulation
of gene expression in vivo.
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